Editorial: The Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) in a New Era of Personalised Medicine

Editorial: The Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) in a New Era of Personalised Medicine

Bibliographic Details
Main Author:	Vera eHirsh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-02-01
Series:	Frontiers in Oncology
Subjects:	lung cancer personalized medicine Supportive Care NSCLC nsclc treatment
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2015.00020/full

Similar Items

Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
Published: (2018)

Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
by: Barbara Melosky
Published: (2017-12-01)

Is the Evaluation of Quality of Life in NSCLC Trials Important? Are the Results to be Trusted?
by: Vera eHirsh
Published: (2014-07-01)

Economic impact of tissue testing and treatments of metastatic NSCLC in the era of personalized medicine.
by: Donna Marie Graham, et al.
Published: (2014-09-01)

The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis
by: Rui Fang, et al.
Published: (2018-11-01)

CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC)
by: Ori Wald
Published: (2018-09-01)

Diagnostics for Targeted NSCLC Therapy
by: Verena Schildgen, et al.
Published: (2017-11-01)

Targeted Treatments of Bone Metastases in Patients with Lung Cancer
by: Vera eHirsh
Published: (2014-06-01)

Role of Radiotherapy in Metastatic Non-small Cell Lung Cancer (NSCLC)
by: Sergio L. Faria
Published: (2014-10-01)

Phase II study of Gemcitabine and Cisplatin Regimen in Advanced Non-Small Cell Lung Cancer (NSCLC).
by: M Hoseinzadeh Mollayosefy, et al.
Published: (2005-06-01)

Phase II study of Gemcitabine and Cisplatin Regimen in Advanced Non-Small Cell Lung Cancer (NSCLC).
by: Hoseinzadeh Mollayosefy M, et al.
Published: (2005-07-01)

Inhaled Cisplatin for NSCLC: Facts and Results
by: Christoforos Kosmidis, et al.
Published: (2019-04-01)

Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)
by: Giustini N, et al.
Published: (2021-03-01)

Surgical Results of Non-small Cell Lung Cancer in Nepal
by: Binay Thakur, et al.
Published: (2014-12-01)

Prolonged survival in advanced squamous cell lung carcinoma by rational and standardized treatment: A case report of long‐term survival in a patient with NSCLC
by: Min Ji, et al.
Published: (2021-03-01)

The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapy
by: Sreeram Ramagopalan, et al.
Published: (2021-09-01)

Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC
by: Alessandro Rossi, et al.
Published: (2021-08-01)

Antitumor effect and molecular mechanism of fucoidan in NSCLC
by: Xiaohan Chen, et al.
Published: (2021-01-01)

Neutrophil–lymphocyte ratio (NLR) predicted prognosis for advanced non-small-cell lung cancer (NSCLC) patients who received immune checkpoint blockade (ICB)
by: Ren F, et al.
Published: (2019-05-01)

Intermediate results of combination therapy in patients with oligometastatic non-small cell lung cancer
by: D. I. Yudin, et al.
Published: (2018-11-01)

Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics
by: Ilija Nenadić, et al.
Published: (2017-07-01)

Immunotherapy in inoperable stage III non-small cell lung cancer: a review
by: Natasha A Jain, et al.
Published: (2019-06-01)

The Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
Published: (2015)

CRP evaluation in non-small cell lung cancer
by: Hassan Aref, et al.
Published: (2014-07-01)

Therapy for patients with non-small cell lung cancer in the Russian Federation: EPICLIN-Lung study
by: S A Tyulyandin, et al.
Published: (2016-12-01)

Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy
by: Umberto Malapelle, et al.
Published: (2021-05-01)

The effects of verteporfin on non-small cell lung cancer
by: Ackerman, Todd R., Jr
Published: (2016)

Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS)
by: Kotoula Vassiliki, et al.
Published: (2012-08-01)

The Effectiveness of PET-Scan in Diagnosis and Treatment of Non-Small Cell Lung Carcinoma (NSCLC) and Lymphoma: A Comprehensive Review of Literature
by: Hamid Ravaghi, et al.
Published: (2012-02-01)

Characteristics of and Treatment Strategies for Advanced EGFR-Mutant NSCLC With Concomitant BRAF Variations
by: Chen, Z.-H, et al.
Published: (2022)

A Systematic Review of Health Economic Evaluation on Targeted Therapies for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Quality Evaluation
by: Zhao J, et al.
Published: (2020-06-01)

PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) Inhibitors
by: Foteinos-Ioannis Dimitrakopoulos, et al.
Published: (2020-05-01)

Albumin-to-alkaline phosphatase ratio at diagnosis predicts survival in patients with metastatic non-small-cell lung cancer
by: Li D, et al.
Published: (2019-07-01)

Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7
by: Jing-Si Wang, et al.
Published: (2020-01-01)

The Effectiveness of PET scan Technology in Diagnosis and Treatment of Non-Small Cell Lung Carcinoma (NSCLC) and Lymphoma: A Systematic Review of Literature
by: Hamid Ravaghi, et al.
Published: (2014-01-01)

The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer
by: Elisabeth Smolle, et al.
Published: (2019-08-01)

Post‐diagnosis weight loss as a prognostic factor in non‐small cell lung cancer
by: Daniel S. Mytelka, et al.
Published: (2018-02-01)

Evaluation of the Preoperative Stage and Operative Findings in Patients With Non-Small Cell Lung Cancer
by: Ademir Hadžismailović, et al.
Published: (2007-08-01)

Challenges with anti-PD1 agents in brain metastases management of NSCLC patients: a case report
by: Alessandro Russo, et al.
Published: (2018-06-01)

Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
by: Michael C. Repka, et al.
Published: (2017-10-01)

Cannot write session to /tmp/vufind_sessions/sess_7lp3sigboh4lfnf8ecp106meri